Goldman Sachs Group set a €53.00 ($61.63) price objective on Aurubis (ETR:NDA) in a research report report published on Tuesday morning. The firm currently has a neutral rating on the stock.
Several other equities analysts have also weighed in on the stock. Kepler Capital Markets set a €60.00 ($69.77) target price on shares of Aurubis and gave the company a buy rating in a report on Tuesday, November 27th. Nord/LB set a €53.00 ($61.63) target price on shares of Aurubis and gave the company a buy rating in a report on Tuesday, November 27th. Commerzbank set a €62.00 ($72.09) price target on shares of Aurubis and gave the stock a neutral rating in a research note on Tuesday, November 27th. Independent Research set a €51.00 ($59.30) price target on shares of Aurubis and gave the stock a neutral rating in a research note on Tuesday, November 27th. Finally, DZ Bank reaffirmed a neutral rating on shares of Aurubis in a research note on Monday, November 26th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of €66.96 ($77.87).
ETR:NDA opened at €43.67 ($50.78) on Tuesday. Aurubis has a twelve month low of €56.64 ($65.86) and a twelve month high of €86.80 ($100.93).
Aurubis AG provides non-ferrous metals worldwide. It operates in two segments, Metal Refining & Processing and Flat Rolled Products. It produces continuous cast, directly cast, and oxygen-free copper rods, as well as various drawn products; shapes in round and square cross-sections, and various dimensions under the AURUBIS SHAPES brand; and copper-based architectural products and services for the building and construction industry, such as flat copper sheets, prefabricated systems for facades, roofs, and rainwater systems.
Read More: Can individual investors take part in an IPO?
Receive News & Ratings for Aurubis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurubis and related companies with MarketBeat.com's FREE daily email newsletter.